
Granules India Limited has informed the Exchange regarding a press release dated Jun 14, 2023, titled "Granules India Limited Receives ANDA Approval forLevetiracetam Tablets".
Filed with NSE ·

Granules India Limited has informed the Exchange regarding a press release dated Jun 14, 2023, titled "Granules India Limited Receives ANDA Approval forLevetiracetam Tablets".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India